<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30568656</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>10</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>09</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1664-3224</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <PubDate>
              <Year>2018</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in immunology</Title>
          <ISOAbbreviation>Front Immunol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sonic Hedgehog Signaling Pathway Mediates Proliferation and Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis <i>via</i> MAPK/ERK Signaling Pathway.</ArticleTitle>
        <Pagination>
          <StartPage>2847</StartPage>
          <MedlinePgn>2847</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">2847</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2018.02847</ELocationID>
        <Abstract>
          <AbstractText>Fibroblast-like synoviocytes (FLSs) are the major effector cells that lead to rheumatoid arthritis (RA) synovitis and joint destruction. Our previous studies showed that Sonic Hedgehog (SHH) signaling pathway is involved in aberrant activation of RA-FLSs and inhibition of SHH pathway decreases proliferation and migration of RA-FLSs. The objective of this study was to investigate if the SHH pathway mediates proliferation and migration of RA-FLSs <i>via</i> the mitogen-activated protein kinases/extracellular signal-regulated kinases (MAPK/ERK) signaling pathway. SHH signaling was studied by using SHH agonist (Purmorphamine) and antagonist (Cyclopamine) targeting the Smoothened (SMO) in FLSs. U0126-EtOH was used to inhibit the MAPK/ERK signaling pathway. The phosphorylation of ERK 1/2 (p-ERKl/2) was examined by western blot. Cell viability was detected using cell proliferation and cytotoxicity kit-8 (CCK8), and cell cycle distribution and proliferating cells were evaluated by the flow cytometry. Cell migration was examined by Transwell assay. Results showed that, compared with the control group, Purmorphamine increased the levels of p-ERK1/2 in concentration-and time-dependent manners (<i>P</i> &lt; 0.01). Co-treated with Purmorphamine and U0126-EtOH or Cyclopamine both decreased the levels of p-ERK1/2 (<i>P</i> &lt; 0.05). RA-FLSs treated with Purmorphamine resulted in alteration of cell cycle distribution, increasing of proliferating cells, cell viability, and migration cells compared to controls (<i>P</i> &lt; 0.01). However, the above phenomenon can be abolished by U0126-EtOH (<i>P</i> &lt; 0.05). The findings suggest that SHH signaling pathway mediates proliferation and migration of RA-FLSs <i>via</i> MAPK/ERK pathway and may contribute to progression of RA. Targeting SHH signaling may have a therapeutic potential in patients with RA.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, The Third Affiliated Hospital Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Xiao Xue</ForeName>
            <Initials>XX</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Shang Ling</ForeName>
            <Initials>SL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Hong Yu</ForeName>
            <Initials>HY</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Arts and Science, University of Toronto, Toronto, ON, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Ying Di</ForeName>
            <Initials>YD</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Yun Feng</ForeName>
            <Initials>YF</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, The Third Affiliated Hospital Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>June</LastName>
            <ForeName>Rayford R</ForeName>
            <Initials>RR</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Milton S. Hershey Medical College at Penn State University, Hershey, PA, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zheng</LastName>
            <ForeName>Song Guo</ForeName>
            <Initials>SG</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Milton S. Hershey Medical College at Penn State University, Hershey, PA, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Jian Lin</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>05</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Immunol</MedlineTA>
        <NlmUniqueID>101560960</NlmUniqueID>
        <ISSNLinking>1664-3224</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C509239">SHH protein, human</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="Y">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000070918" MajorTopicYN="N">Synoviocytes</DescriptorName>
          <QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">MAPK/ERK</Keyword>
        <Keyword MajorTopicYN="Y">Sonic Hedgehog</Keyword>
        <Keyword MajorTopicYN="Y">arthritis</Keyword>
        <Keyword MajorTopicYN="Y">cell migration</Keyword>
        <Keyword MajorTopicYN="Y">cell proliferation</Keyword>
        <Keyword MajorTopicYN="Y">mitogen-activated protein kinases</Keyword>
        <Keyword MajorTopicYN="Y">rheumatoid</Keyword>
        <Keyword MajorTopicYN="Y">signal transduction</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>7</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>12</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>10</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30568656</ArticleId>
        <ArticleId IdType="pmc">PMC6290332</ArticleId>
        <ArticleId IdType="doi">10.3389/fimmu.2018.02847</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. 
Rheumatoid arthritis. Nat Rev Dis Primers (2018) 4:18001
10.1038/nrdp.2018.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrdp.2018.1</ArticleId>
            <ArticleId IdType="pubmed">29417936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu Y, Pan YF, Xue YQ, Fang LK, Guo XH, Guo X, et al. . uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis. Cell Mol Immunol. (2018) 15:171–81. 10.1038/cmi.2016.60</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cmi.2016.60</ArticleId>
            <ArticleId IdType="pmc">PMC5811678</ArticleId>
            <ArticleId IdType="pubmed">28090093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo BY, Guo XH, Yang MR, Liu F, Bi X, Liu Y, et al. . Long non-coding RNA GAPLINC promotes tumor-like biologic behaviors of fibroblast-like synoviocytes as microRNA sponging in rheumatoid arthritis patients. Front Immunol. (2018) 9:702. 10.3389/fimmu.2018.00702</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2018.00702</ArticleId>
            <ArticleId IdType="pmc">PMC5902673</ArticleId>
            <ArticleId IdType="pubmed">29692777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smolen JS, Aletaha D, McInnes IB.
Rheumatoid arthritis. Lancet (2016) 388:1023–2038. 10.1016/S0140-6736(16)30173-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(16)30173-8</ArticleId>
            <ArticleId IdType="pubmed">27156434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. (2013) 9:24–33. 10.1038/nrrheum.2012.190</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrrheum.2012.190</ArticleId>
            <ArticleId IdType="pmc">PMC3970924</ArticleId>
            <ArticleId IdType="pubmed">23147896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet (2017) 389:2328–37. 10.1016/S0140-6736(17)31472-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(17)31472-1</ArticleId>
            <ArticleId IdType="pubmed">28612747</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aupperle K, Bennett B, Han Z, Boyle D, Manning A, Firestein G.
NF-κB regulation by IκB kinase-2 in rheumatoid arthritis synoviocytes. J Immunol. (2001) 166:2705–11. 10.4049/jimmunol.166.4.2705</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.166.4.2705</ArticleId>
            <ArticleId IdType="pubmed">11160335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ralph JA, Morand EF. MAPK phosphatases as novel targets for rheumatoid arthritis. Expert Opin Ther Targets (2008) 12:795–808. 10.1517/14728222.12.7.795</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1517/14728222.12.7.795</ArticleId>
            <ArticleId IdType="pubmed">18554149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsia EYC, Zhang Y, Tran HS, Lim A, Chou YH, Lan G, et al. . Hedgehog mediated degradation of Ihog adhesion proteins modulates cell segregation in Drosophila wing imaginal discs. Nat Commun. (2017) 8:1275. 10.1038/s41467-017-01364-z</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-017-01364-z</ArticleId>
            <ArticleId IdType="pmc">PMC5668237</ArticleId>
            <ArticleId IdType="pubmed">29097673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brechbiel J, Miller-Moslin K, Adjei AA. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer. Cancer Treat Rev. (2014) 40:750–9. 10.1016/j.ctrv.2014.02.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ctrv.2014.02.003</ArticleId>
            <ArticleId IdType="pubmed">24613036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: a comprehensive review. Bosn J Basic Med Sci. (2017) 18:8–20. 10.17305/bjbms.2018.2756</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17305/bjbms.2018.2756</ArticleId>
            <ArticleId IdType="pmc">PMC5826678</ArticleId>
            <ArticleId IdType="pubmed">29274272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang M, Zhu S, Peng W, Li Q, Li Z, Luo M, et al. . Sonic hedgehog signaling drives proliferation of synoviocytes in rheumatoid arthritis: a possible novel therapeutic target. J Immunol Res. (2014) 2014:401903. 10.1155/2014/401903</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/401903</ArticleId>
            <ArticleId IdType="pmc">PMC3987882</ArticleId>
            <ArticleId IdType="pubmed">24741597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu SL, Huang JL, Peng WX, Wu DC, Luo MQ, Li QX, et al. . Inhibition of smoothened decreases proliferation of synoviocytes in rheumatoid arthritis. Cell Mol Immunol. (2017) 14:214–22. 10.1038/cmi.2015.67</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cmi.2015.67</ArticleId>
            <ArticleId IdType="pmc">PMC5301154</ArticleId>
            <ArticleId IdType="pubmed">26189371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng WX, Zhu SL, Zhang BY, Shi YM, Feng XX, Liu F, et al. . Smoothened regulates migration of fibroblast-like synoviocytes in rheumatoid arthritis via activation of Rho GTPase signaling. Front Immunol. (2017) 8:159. 10.3389/fimmu.2017.00159</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2017.00159</ArticleId>
            <ArticleId IdType="pmc">PMC5309251</ArticleId>
            <ArticleId IdType="pubmed">28261216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ertao Z, Jianhui C, Chuangqi C, Changjiang Q, Sile C, Yulong H, et al. . Autocrine Sonic hedgehog signaling promotes gastric cancer proliferation through induction of phospholipase Cγ1 and the ERK1/2 pathway. J Exp Clin Cancer Res. (2016) 35:63. 10.1186/s13046-016-0336-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-016-0336-9</ArticleId>
            <ArticleId IdType="pmc">PMC4818860</ArticleId>
            <ArticleId IdType="pubmed">27039174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu JT, Zhao WD, He W, Wei W. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway. Acta Pharmacol Sin. (2012) 33:691–700. 10.1038/aps.2012.24</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/aps.2012.24</ArticleId>
            <ArticleId IdType="pmc">PMC4010360</ArticleId>
            <ArticleId IdType="pubmed">22543708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young CD, Zimmerman LJ, Hoshino D, Formisano L, Hanker AB, Gatza ML, et al. . Activating PIK3CA mutations induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) paracrine signaling axis in basal-like breast cancer. Mol Cell Proteomics (2015) 14:1959–76. 10.1074/mcp.M115.049783</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/mcp.M115.049783</ArticleId>
            <ArticleId IdType="pmc">PMC4587316</ArticleId>
            <ArticleId IdType="pubmed">25953087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. . The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. (1988) 31:315–24. 10.1002/art.1780310302</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.1780310302</ArticleId>
            <ArticleId IdType="pubmed">3358796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Briscoe J, Thérond PP.
The mechanisms of Hedgehog signaling and its roles in development and disease. Nat Rev Mol Cell Biol. (2013) 14:416–29. 10.1038/nrm3598</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3598</ArticleId>
            <ArticleId IdType="pubmed">23719536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robbins DJ, Fei DL, Riobo NA. The Hedgehog signal transduction network. Sci Signal (2012) 5:re6. 10.1126/scisignal.2002906</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scisignal.2002906</ArticleId>
            <ArticleId IdType="pmc">PMC3705708</ArticleId>
            <ArticleId IdType="pubmed">23074268</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee ST, Welch KD, Panter KE, Gardner DR, Garrossian M, Chang CW. Cyclopamine: from cyclops lambs to cancer treatment. J Agric Food Chem. (2014) 62:7355–62. 10.1021/jf5005622</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf5005622</ArticleId>
            <ArticleId IdType="pubmed">24754790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roskoski R, Jr. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res. (2012) 66:105–43. 10.1016/j.phrs.2012.04.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.phrs.2012.04.005</ArticleId>
            <ArticleId IdType="pubmed">22569528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang H, Li Q, Moraes RC, Lewis MT, Hamel PA.
Activation of Erk by sonic hedgehog independent of canonical hedgehog signaling. Int J Biochem Cell Biol. (2010) 42:1462–71. 10.1016/j.biocel.2010.04.016</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biocel.2010.04.016</ArticleId>
            <ArticleId IdType="pmc">PMC3038129</ArticleId>
            <ArticleId IdType="pubmed">20451654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mimeault M, Batra SK. Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacol Rev. (2010) 62:497–524. 10.1124/pr.109.002329</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/pr.109.002329</ArticleId>
            <ArticleId IdType="pmc">PMC2964899</ArticleId>
            <ArticleId IdType="pubmed">20716670</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elia D, Madhala D, Ardon E, Reshef R, Halevy O. Sonic hedgehog promotes proliferation and differentiation of adult muscle cells: involvement of MAPK/ERK and PI3K/Akt pathways. Biochim Biophys Acta (2007) 1773:1438–46. 10.1016/j.bbamcr.2007.06.006</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbamcr.2007.06.006</ArticleId>
            <ArticleId IdType="pubmed">17688959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ayers KL, Thérond PP.
Evaluating smoothened as a G-protein-coupled receptor for Hedgehog signaling. Trends Cell Biol. (2010) 20:287–98. 10.1016/j.tcb.2010.02.002</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tcb.2010.02.002</ArticleId>
            <ArticleId IdType="pubmed">20207148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eishingdrelo H, Kongsamut S. Minireview: targeting GPCR activated ERK pathways for drug discovery. Curr Chem Genom Transl Med. (2013) 7:9–15. 10.2174/2213988501307010009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/2213988501307010009</ArticleId>
            <ArticleId IdType="pmc">PMC3854659</ArticleId>
            <ArticleId IdType="pubmed">24396730</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schett G, Tohidast-Akrad M, Smolen JS, Schmid BJ, Steiner CW, Bitzan P, et al. . Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum. (2000) 43:2501–12. 10.1002/1529-0131(200011)43:11&lt;2501::AID-ANR18&gt;3.0.CO;2-K</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1529-0131(200011)43:11&lt;2501::AID-ANR18&gt;3.0.CO;2-K</ArticleId>
            <ArticleId IdType="pubmed">11083274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thiel MJ, Schaefer CJ, Lesch ME, Mobley JL, Dudley DT, Tecle H, et al. . Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms. Arthritis Rheum. (2007) 56:3347–57. 10.1002/art.22869</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.22869</ArticleId>
            <ArticleId IdType="pubmed">17907188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Neff L, Zeisel M, Druet V, Takeda K, Klein JP, Sibilia J, et al. . ERK 1/2- and JNKs-dependent synthesis of interleukins 6 and 8 by fibroblast-like synoviocytes stimulated with protein I/II, a modulin from oral streptococci, requires focal adhesion kinase. J Biol Chem. (2003) 278:27721–8. 10.1074/jbc.M212065200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M212065200</ArticleId>
            <ArticleId IdType="pubmed">12761229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morel J, Audo R, Hahne M, Combe B. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt. J Biol Chem. (2005) 280:15709–18. 10.1074/jbc.M414469200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M414469200</ArticleId>
            <ArticleId IdType="pubmed">15684417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowin T, Straub RH, Neumann E, Bosserhoff A, Vogel C, Moissl C, et al. . Glucocorticoids increase alpha5 integrin expression and adhesion of synovial fibroblasts but inhibit ERK signaling, migration, and cartilage invasion. Arthritis Rheum. (2009) 60:3623–32. 10.1002/art.24985</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.24985</ArticleId>
            <ArticleId IdType="pubmed">19950288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashiramoto A, Sakai C, Yoshida K, Tsumiyama K, Miura Y, Shiozawa K, et al. . Angiopoietin 1 directly induces destruction of the rheumatoid joint by cooperative, but independent, signaling via ERK/MAPK and phosphatidylinositol 3-kinase/Akt. Arthritis Rheum. (2007) 56:2170–9. 10.1002/art.22727</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.22727</ArticleId>
            <ArticleId IdType="pubmed">17599743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim WU, Kang SS, Yoo SA, Hong KH, Bae DG, Lee MS, et al. . Interaction of vascular endothelial growth factor 165 with neuropilin-1 protects rheumatoid synoviocytes from apoptotic death by regulating Bcl-2 expression and Bax translocation. J Immunol. (2006) 177:5727–35. 10.4049/jimmunol.177.8.5727</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.177.8.5727</ArticleId>
            <ArticleId IdType="pubmed">17015762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu Q, Li T, Wang L, Xie Y, Liu S, Bai X, et al. . Neuroprotective effects of a smoothened receptor agonist against early brain injury after experimental subarachnoid hemorrhage in rats. Front Cell Neurosci. (2016) 10:306. 10.3389/fncel.2016.00306</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2016.00306</ArticleId>
            <ArticleId IdType="pmc">PMC5241312</ArticleId>
            <ArticleId IdType="pubmed">28149272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banerjee J, Papu John AM, Schuller HM. Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides. Int J Cancer (2015) 137:2815–24. 10.1002/ijc.29646</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.29646</ArticleId>
            <ArticleId IdType="pmc">PMC4600645</ArticleId>
            <ArticleId IdType="pubmed">26088878</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
